Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Classement en actions #29819
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Prix de l'action
$7.00
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$19.47M
Changement (1 jour)
0.00%
Changement (1 an)
-35.19%
Pays
CA
Échange Devonian Health Group Inc. (DVHGF)

Catégorie

Historique du prix de l'action pour Devonian Health Group Inc. (DVHGF)
Prix de clôture le plus élevé : $7.00 le 2026-08-01

Prix de clôture le plus bas : $35.44 le 2022-09-01
Historique du prix de l'action de Devonian Health Group Inc. de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 73.19%
2025 -46.13%
2024 -38.22%
2023 -14.47%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$744.18 7.27%
CH
$1.07K -5.58%
KR